SCIENTIFIC PUBLICATIONS

2021

Innovative biodegradable dibutyrylchitin dressing for the treatment of ulcers occurring during chronic venous insufficiency in patients with type 2 diabetes. Int J Occup Med Environ Health. 2021 Jan 8; 130534.

2019

EGFRvIII: An Oncogene with Ambiguous Role. J Oncol. 2019 Dec 16; 2019: 1092587.

A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells – possible approaches to circumvent these phenomena. BMC Cancer. 2019 Sep 14; 19 (1): 923.

2018

Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation. Oncotarget 2018; 9: 8560-8572.

2017

Low Incidence along with Low mRNA Levels of EGFRvIII in Prostate and Colorectal Cancers Compared to Glioblastoma. J Cancer. 2017 Jan 1; 8 (1): 146-151.

2016

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors. J Transl Med. 2016 Dec 20; 14 (1): 341.

Efficient and simple approach to in vitro culture of primary epithelial cancer cells. Biosci Rep. 2016 Dec 9; 36 (6).

EGFR Activation Leads to Cell Death Independent of PI3K / AKT / mTOR in an AD293 Cell Line. PLoS One. 2016 May 6; 11 (5): e0155230.

IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis. PLoS One. 2016 May 4; 11 (5): e0154726.

Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes. Oncotarget. 2016 May 31; 7 (22): 31907-25.

Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line. OncolLett. 2016 Jan; 11 (1): 593-599.

Synthesis and physicochemical characterization of chitin dihexanoate – A new biocompatible chitin derivative – In comparison to chitin dibutyrate. MaterSciEng C MaterBiolAppl. 2016 Mar; 60: 489-502.

2015

SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence. PLoS One. 2015 Nov 4; 10 (11): e0141688.

Chitin dipentanoate as the new technologically usable biomaterial. MaterSciEng C MaterBiolAppl. 2015 Oct; 55: 50-60.

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP / EBNA-1 episomal reprogramming system. Stem Cell Res Ther. 2015 Jun 19; 6: 122.

Sensitivity of neoplastic cells to senescence unveiled under standard cell culture conditions. Anticancer Res. 2015 May; 35 (5): 2759-68.

2014

Novel injectable biomaterials for bone augmentation based on isosorbide dimethacrylic monomers. MaterSciEng C MaterBiolAppl. 2014 Jul 1; 40: 76-84.